Ovid Therapeutics Inc (OVID)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,433 | -52,339 | -54,169 | 122,835 | -81,036 |
| Depreciation Amortization | 613 | 568 | 1,382 | 237 | 307 |
| Accounts receivable | N/A | N/A | N/A | 142 | N/A |
| Accounts payable and accrued liabilities | -512 | 1,750 | -5,174 | 1,703 | 2,334 |
| Other Working Capital | -150 | 2,386 | -8,232 | -16,815 | 21,819 |
| Other Operating Activity | -29,474 | 1,854 | 10,966 | 10,510 | 4,992 |
| Operating Cash Flow | $-55,956 | $-45,781 | $-55,227 | $118,612 | $-51,584 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 54,754 | 7,557 | -83,965 | N/A | 35,039 |
| PPE Investments | -71 | -40 | -1,224 | -184 | -127 |
| Purchase Of Investment | N/A | -10,000 | -2,500 | -1,632 | N/A |
| Purchase Sale Intangibles | -90 | -97 | -194 | -5 | -263 |
| Other Investing Activity | -89 | -98 | -194 | -5 | -264 |
| Investing Cash Flow | $54,594 | $-2,581 | $-87,883 | $-1,821 | $34,648 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 622 | 535 | 181 | 925 | 47,236 |
| Other Financing Activity | 0 | 30,000 | 0 | -21 | -163 |
| Financing Cash Flow | $622 | $30,535 | $181 | $904 | $47,073 |
| Beginning Cash Position | 28,972 | 46,799 | 189,728 | 72,034 | 41,897 |
| End Cash Position | 28,232 | 28,972 | 46,799 | 189,728 | 72,034 |
| Net Cash Flow | $-740 | $-17,826 | $-142,930 | $117,694 | $30,137 |
| Free Cash Flow | |||||
| Operating Cash Flow | -55,956 | -45,781 | -55,227 | 118,612 | -51,584 |
| Capital Expenditure | -71 | -40 | -1,224 | -184 | -127 |
| Free Cash Flow | -56,027 | -45,821 | -56,452 | 118,428 | -51,711 |